Mon.Jan 29, 2024

article thumbnail

Scientists document first-ever transmitted Alzheimer’s cases, tied to no-longer-used medical procedure

STAT

LONDON — There was something odd about these Alzheimer’s cases. Part of it was the patients’ presentations: Some didn’t have the classic symptoms of the condition. But it was also that the patients were in their 40s and 50s, even their 30s, far younger than people who normally develop the disease. They didn’t even have the known genetic mutations that can set people on the course for such early-onset Alzheimer’s.

article thumbnail

Tonix closes in on the first new fibromyalgia drug in more than a decade

PharmaVoice

In addition to the chronic disease, the non-opioid drug may have applications in other painful conditions.

300
300
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Opinion: I’m an anesthesiologist. Kenneth Smith’s execution by nitrogen gas was far from ‘textbook’

STAT

On Thursday evening, the state of Alabama executed Kenneth Eugene Smith by nitrogen gas. Now, there are dueling narratives about what happened. Alabama claims it went perfectly, proving that nitrogen is a humane, effective alternative to lethal injection (which it previously tried, unsuccessfully, to use on Smith). It says that based on this experience, other states should follow its example.

363
363
article thumbnail

SAEM Clinical Images Series: Retrobulbar Spot Sign

ALiEM - Pharm Pearls

A 59-year-old male with no known past medical history other than an incidental abdominal aortic aneurysm presented with sudden onset, painless vision loss in his left eye. The patient was watching TV two days prior when he saw a “brightness” in his left eye and then progressive blurriness until his vision faded away, all occurring within the span of a minute.

161
161
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Pricey sickle cell treatments raise daunting new challenges for Medicaid programs

STAT

Living with sickle cell disease has not been easy on Kourtney Cunningham. The genetic blood disorder typically causes her to experience three episodes of extreme pain each month and she can end up in the hospital at least twice a year due to these crises. Then there are blood transfusions every four weeks.

Hospitals 361
article thumbnail

AstraZeneca, Daiichi aim for first pan-tumor ADC approval

PharmaVoice

A “tumor agnostic” FDA approval for the companies’ Enhertu would break new ground for antibody-drug conjugates.

130
130

More Trending

article thumbnail

Merck is on the lookout for more opportunities within immunology

Pharmaceutical Technology

At the JP Morgan Healthcare conference, Merck (MSD) indicated its eagerness to continue to establish its place in the immunological space.

144
144
article thumbnail

Opinion: Which country has the best health care? That’s the wrong question

STAT

I’ve spent my career studying how different health care systems work. People love to ask me which country has the best care — and are often disappointed when I don’t have an easy answer for them. Every health care model involves people doing their best to balance competing priorities in the face of limited resources. In other words, every system involves tradeoffs.

363
363
article thumbnail

AstraZeneca, Daiichi aim for first pan-tumor ADC approval

BioPharma Dive

The FDA is reviewing the companies’ application for a “tumor agnostic” indication for their drug Enhertu, which would break new ground for antibody-drug conjugates.

121
121
article thumbnail

STAT+: Cognito raises $35 million for Alzheimer’s treatment device, touts benefits compared to drugs

STAT

Just as a new wave of approved drugs for Alzheimer’s disease reaches patients, medical device company Cognito Therapeutics has raised a fresh $35 million to advance its alternative treatment for the neurodegenerative disease. With the new Series B extension funding, the Cambridge, Mass.-based company has now raised $128 million to develop its headset that uses gamma frequency light and sound stimulation to combat the cognitive decline that’s the hallmark of Alzheimer’s.

345
345
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

First impressions matter: Why getting your onboarding right is key for digital engagement

pharmaphorum

Creating a positive onboarding experience is crucial for engaging healthcare professionals (HCPs) in digital platforms and utilising data effectively. Discover why first impressions matter and how to get your onboarding process right for optimal digital engagement.

121
121
article thumbnail

23andMe breach targeted Chinese, Jewish populations

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hey there. Today, we discuss how Medicaid might pay for the costly but potentially curative sickle cell gene therapies, as well as the shocking lawsuit that outlines a data breach at 23andMe that targets Chinese and Jewish customers.

article thumbnail

Pharmaceutical industry: 2023 in retrospect

European Pharmaceutical Review

N-Nitrosamines By far the biggest issue bedevilling industry during 2023 was the continuing N-nitrosamine contamination saga, which was covered in the third issue of EPR 2023. 1 Some five years after the initial NDMA (N-nitrosodimethylamine) contamination issue 2 initially affecting valsartan drug substance, then other active pharmaceutical ingredients (APIs), eg, sartans, ranitidine, metformin, etc; the toxic short alkyl chain N-nitrosamine issue appears, if not resolved, then well on the way t

article thumbnail

STAT+: European regulators tout their accomplishments against pharma’s anticompetitive practices

STAT

European antitrust regulators want you to know that fighting crime in the pharmaceutical industry pays. Between 2018 and 2022, the European Commission and antitrust regulators in numerous European countries adopted 26 decisions concerning anti-competitive practices by drug companies by imposing more than $845 million in fines or accepting legally binding commitments by manufacturers to alter their corporate behaviors.

281
281
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Ron Lanton, Partner, Lanton Law PLLC, Discusses New Drug Plus Pricing Models

Pharmaceutical Commerce

In an interview with Pharma Commerce Associate Editor Don Tracy, Ron Lanton, Partner, Lanton Law PLLC, discusses recent moves by CVS and Express Scripts to follow Mark Cuban's drug plus model.

110
110
article thumbnail

STAT+: Pharmalittle: We’re reading about Medicaid and sickle cell, pharma CEOs, and more

STAT

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of online meetings, phone calls, and deadlines has returned. But you knew this would happen, yes? After all, the world, such as it is, continues to spin. So time to nudge it in a better direction with a cup or two of delicious stimulation.

Diabetes 261
article thumbnail

Grifols sues Gotham City over fraud allegations

pharmaphorum

Spanish drugmaker Grifols has hit back at hedge fund Gotham City Research, which claimed it had fraudulently manipulated its financial reporting, with a lawsuit filed in New York. The complaint has been brought against Gotham City and co-founders Daniel Yu and Cyrus de Weck, along with other defendants, and accuses them of being “predatory short sellers…who illicitly profit from their rigged short-and-distort schemes.

111
111
article thumbnail

Moderna leads the development of mRNA vaccines in infectious diseases

Pharmaceutical Technology

The rapid sequencing of the SARS-CoV-2 and the subsequent development of mRNA vaccines led to the authorisation of the first of these vaccines in late 2020.

Vaccines 111
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

BMS subcutaneous Opdivo clears first phase 3 trial

pharmaphorum

Bristol-Myers Squibb is getting closer to offering a subcutaneous version of its cancer immunotherapy Opdivo to patients after it matched the current intravenous formulation in a head-to-head trial in kidney cancer.

108
108
article thumbnail

Medicines for Europe calls for simpler SPC manufacturing waiver

European Pharmaceutical Review

According to Medicines for Europe, the Munich District Court’s Supplementary Protection Certificate (SPC) manufacturing waiver , issued in Germany in October 2023, is “in conflict” with the objectives of the waiver. The organisation and its members are “strongly concerned” by the court’s first judgement of the waiver. SPC manufacturing waiver Aims and challenges First enacted in 2019, the goal of the SPC manufacturing waiver is to enable the manufacture of medicines, under certain conditions, du

article thumbnail

Moderna leads development of mRNA vaccines in infectious diseases: GlobalData

Express Pharma

The global messenger ribonucleic acid (mRNA) vaccines market currently consists entirely of vaccines for COVID-19. The rapid sequencing of the SARS-CoV-2 viral genome and the subsequent development of mRNA vaccines in response to the pandemic led to the authorisation of the first of these vaccines in December 2020. However, several pharma companies have mRNA vaccines in late-stage development for other infectious diseases, with Moderna dominating in terms of research and development (R&D) in

Vaccines 108
article thumbnail

Revised ISO guideline highlights toxicological evaluation of extractables and leachables

European Pharmaceutical Review

In the published in 2023, the process and requirements for toxicological risk assessment of medical device constituents is outlined. Also covered in the guideline are “the methods and criteria used to assess whether exposure to a constituent is without appreciable harm”. As highlighted by the International Organization for Standardization (ISO), the process described in the standard is relevant to chemical characterisation, such as extractable data or leachable data ( E&L ), information obta

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

CPE stresses need for Pharmacy First awareness with publicity launch

The Pharmacist

A series of resources to help pharmacists promote the incoming Pharmacy First service has been made available by Community Pharmacy England (CPE). The launch date for the new service has been confirmed as 31 January, and CPE emphasised that for its self-referral (walk-in) aspect to be a success, the general public and patients need to […] The post CPE stresses need for Pharmacy First awareness with publicity launch appeared first on The Pharmacist.

article thumbnail

GSK’s Omjjara EU-cleared for splenomegaly in myelofibrosis

pharmaphorum

GSK has claimed EU approval of Omjjara for the treatment of splenomegaly or symptoms in adult myelofibrosis patients with moderate-to-severe anaemia

109
109
article thumbnail

The Link Between Calcium Intake and Strong Bones

Welltopia Pharmacy

Boost Calcium Intake and Strong Bones with Welltopia's Calcium Reserve, the key to enhanced bone health and osteoporosis prevention.

105
105
article thumbnail

Keytruda improves survival in early-stage kidney cancer

pharmaphorum

MSD’s Keytruda is the first cancer immunotherapy to improve survival when used as adjuvant therapy in renal cell carcinoma (RCC).

115
115
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Key achievement for Repare Therapeutics after receipt of $40 million Roche payment

Outsourcing Pharma

Clinical-stage precision oncology company, Repare Therapeutics Inc., has received a $40 million milestone payment from Roche after dosing the first patient in a clinical trial.

97
article thumbnail

Expert Speak | Saif Mehkri, Founder & Director, Bio-gen Extracts Pvt. Ltd.

Express Pharma

Express Pharma – Nutrify Today Boardroom series offers a platform for meaningful dialogues on the vast ocean of opportunities in nutraceuticals, provided the right course is set for long and sustainable growth. In this video, Saif Mehkri, one of the three co-founders of Bio-gen, speaks about starting from a 1000 square feet facility, with one angel investor to becoming one of India’s largest nutrition ingredients companies in 23 years.

Dosage 103
article thumbnail

Ascidian launches first-ever clinical study of RNA exon editor for vision loss

Pharmaceutical Technology

An eye-catching milestone in hand, Ascidian will begin the Phase I/II STELLAR study of ACDN-01 for Stargardt disease in H1 2024.

104
104
article thumbnail

NHS delivers a further 5,000 permanent hospital beds

Pharma Times

A total of 103,277 general and acute beds are now available to NHS patients

Hospitals 121
article thumbnail

Cell and gene therapies – top pharmaceutical industry trend to watch for 2024

Pharmaceutical Technology

The full potential of cell and gene therapies (CGTs) has not yet been discovered as these therapies promise life-changing treatments.

97